353 related articles for article (PubMed ID: 27484063)
1. Perifollicular blood flow and its relationship with endometrial vascularity, follicular fluid EG-VEGF, IGF-1, and inhibin-a levels and IVF outcomes.
Vural F; Vural B; Doğer E; Çakıroğlu Y; Çekmen M
J Assist Reprod Genet; 2016 Oct; 33(10):1355-1362. PubMed ID: 27484063
[TBL] [Abstract][Full Text] [Related]
2. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome?
Ocal P; Aydin S; Cepni I; Idil S; Idil M; Uzun H; Benian A
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):194-9. PubMed ID: 15262355
[TBL] [Abstract][Full Text] [Related]
3. Follicular fluid VEGF levels directly correlate with perifollicular blood flow in normoresponder patients undergoing IVF.
Monteleone P; Giovanni Artini P; Simi G; Casarosa E; Cela V; Genazzani AR
J Assist Reprod Genet; 2008 May; 25(5):183-6. PubMed ID: 18449636
[TBL] [Abstract][Full Text] [Related]
4. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization.
Fried G; Remaeus K; Harlin J; Krog E; Csemiczky G; Aanesen A; Tally M
J Assist Reprod Genet; 2003 May; 20(5):167-76. PubMed ID: 12812459
[TBL] [Abstract][Full Text] [Related]
5. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development.
Wang TH; Chang CL; Wu HM; Chiu YM; Chen CK; Wang HS
Fertil Steril; 2006 Nov; 86(5):1392-401. PubMed ID: 17070193
[TBL] [Abstract][Full Text] [Related]
7. Effects of EG-VEGF, VEGF and TGF-β1 on pregnancy outcome in patients undergoing IVF-ET treatment.
Gao MZ; Zhao XM; Lin Y; Sun ZG; Zhang HQ
J Assist Reprod Genet; 2012 Oct; 29(10):1091-6. PubMed ID: 22847371
[TBL] [Abstract][Full Text] [Related]
8. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
9. Prokineticin 1 is a new biomarker of human oocyte competence: expression and hormonal regulation throughout late folliculogenesis.
Alfaidy N; Baron C; Antoine Y; Reynaud D; Traboulsi W; Gueniffey A; Lamotte A; Melloul E; Dunand C; Villaret L; Bessonnat J; Mauroy C; Boueihl T; Coutton C; Martinez G; Hamamah S; Hoffmann P; Hennebicq S; Brouillet S
Biol Reprod; 2019 Oct; 101(4):832-841. PubMed ID: 31276578
[TBL] [Abstract][Full Text] [Related]
10. Perifollicular vascularity in poor ovarian responders during IVF.
Kan A; Ng EH; Yeung WS; Ho PC
Hum Reprod; 2006 Jun; 21(6):1539-44. PubMed ID: 16488903
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D as a follicular marker of human oocyte quality and a serum marker of in vitro fertilization outcome.
Ciepiela P; Dulęba AJ; Kowaleczko E; Chełstowski K; Kurzawa R
J Assist Reprod Genet; 2018 Jul; 35(7):1265-1276. PubMed ID: 29774457
[TBL] [Abstract][Full Text] [Related]
12. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
[TBL] [Abstract][Full Text] [Related]
13. Cell-free DNA in human follicular fluid as a biomarker of embryo quality.
Scalici E; Traver S; Molinari N; Mullet T; Monforte M; Vintejoux E; Hamamah S
Hum Reprod; 2014 Dec; 29(12):2661-9. PubMed ID: 25267787
[TBL] [Abstract][Full Text] [Related]
14. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
15. Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization.
Dorn C; Reinsberg J; Kupka M; van der Ven H; Schild RL
Arch Gynecol Obstet; 2003 Aug; 268(3):187-93. PubMed ID: 12942249
[TBL] [Abstract][Full Text] [Related]
16. Impact of serum and follicular fluid kisspeptin and estradiol on oocyte maturity and endometrial thickness among unexplained infertile females during ICSI.
Rehman R; Zafar A; Ali AA; Baig M; Alam F
PLoS One; 2020; 15(10):e0239142. PubMed ID: 33112855
[TBL] [Abstract][Full Text] [Related]
17. Follicular blood flow is a better predictor of the outcome of in vitro fertilization-embryo transfer than follicular fluid vascular endothelial growth factor and nitric oxide concentrations.
Kim KH; Oh DS; Jeong JH; Shin BS; Joo BS; Lee KS
Fertil Steril; 2004 Sep; 82(3):586-92. PubMed ID: 15374700
[TBL] [Abstract][Full Text] [Related]
18. Follicular fluid vascular endothelial growth factor is associated with type of infertility and interferon alpha correlates with endometrial thickness in natural cycle in vitro fertilization.
Hafner D; Zivkovic SV; Bauman R; Tiljak K; Papić N; Lepej SZ
Reprod Biol; 2018 Sep; 18(3):289-294. PubMed ID: 29945770
[TBL] [Abstract][Full Text] [Related]
19. Cell-free nucleic acids and melatonin levels in human follicular fluid predict embryo quality in patients undergoing in-vitro fertilization treatment.
Latif Khan H; Bhatti S; Latif Khan Y; Abbas S; Munir Z; Rahman Khan Sherwani IA; Suhail S; Hassan Z; Aydin HH
J Gynecol Obstet Hum Reprod; 2020 Jan; 49(1):101624. PubMed ID: 31472269
[TBL] [Abstract][Full Text] [Related]
20. Follicular fluid concentrations of IGF-I, IGF-II, IGFBP-3, VEGF, AMH, and inhibin-B in women undergoing controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist.
Kaya A; Atabekoglu CS; Kahraman K; Taskin S; Ozmen B; Berker B; Sonmezer M
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):167-71. PubMed ID: 22776750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
